Research Reports

Healthcare

icon
Home » Reports » Upstream Bioprocessing Equipment Market
Market Research Report

Upstream Bioprocessing Equipment Market By Cell line (Microbial, Mammalian); By Processing (Single – use bioprocessing system, Continuous bioprocessing systems); By End-User (Pharmaceutical & Biological Manufacturing Companies, Research Centers) - Global Demand Analysis & Opportunity Outlook 2027

Published On : 05:47 AM, 31st July, 2018 REP-ID-628 Category: Healthcare

Global Upstream Bioprocessing Equipment Market Overview

Bioprocess is a comprehensive term surrounding the R&D, assembling, and commercialization of products arranged from or utilized by natural frameworks, including fuels, food, feed, biopharmaceuticals, and cosmetics. Bio processes can be separated into upstream processes and downstream processes. The upstream procedure is portrayed as the entire procedure from early cell segregation, isolation and cultivation, to cell banking and culture extension of the cells until final harvest (end of the way of life and gathering of the live cell clump).

The Upstream process involves steps such as media development, cell culture, and development, harvesting of cells and fermentation. These processes are done under strict sterile conditions, and particular temperature and pH levels maintained throughout the process. Cell Banking is also done by upstream processes. The primary objective behind upstream processes is to provide an environment necessary for the growth of cells. This can be best done in large scale with a bioreactor which can be used for various applications such as fermentation; stem cell development; strain selection and cell-line optimization; bioprocess development; early cell screening and media selection; and producing monoclonal antibodies, vaccines and recombinant proteins.

Market Size & Forecast

Upstream bioprocessing equipment market is anticipated to record a significant CAGR over the forecast period. The increasing demand for production of therapeutic proteins, antibiotics, hormones, enzymes, blood substitutes, and vaccines are expected to increase the market demand due to the manufacturing of these products by the help of upstream bioprocessing equipment. At present the global upstream bioprocessing equipment market is observing vibrant growth owing to increasing demand of proteins due to diseases like lymphoma, rheumatoid arthritis, diabetes mellitus and growth hormone insufficiency that can be treated by specific proteins produced from bioprocesses.

On the basis of regional platform, global Upstream Bioprocessing Equipment market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. North-America is expected to hold a strong position in upstream bioprocessing equipment market followed by Europe. These two regions are estimated to prosper at a robust rate during the forecast year owing to large-scale use of single-use bioprocessing systems.

Asia-Pacific is estimated to be a potentially lucrative region over the forecast period. The rising diversification in the food, beverages and pharmaceutical industry in the developing regions are expected to increase the market growth. For instance, the government in some developing countries provides financial support for R&D activities which helps the industry prosper.

Upstream Bioprocessing Equipment Market

Market Segmentation

Our-in depth analysis of the global Upstream Bioprocessing Equipment market includes the following segments:

By Cell line

  • Microbial
    • Bacterial
    • Yeast
    • Viral
  • Mammalian

By Processing

  • Single – use bioprocessing system
  • Continuous bioprocessing systems

By End-User

  • Pharmaceutical & Biological Manufacturing Companies
  • Research Centers

By Region

Global Upstream Bioprocessing Equipment Market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of Asia) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Upstream-Bioprocessing-Equipment-Market-Share

Growth Drivers & Challenges

It’s been over a decade that single-use processing units have achieved thrust as it is possible to develop a small amount of drugs used for preclinical and clinical testing using these processes. As the occurrence and frequency of chronic diseases have augmented, there is a requirement to boost the production of substances to cure them. With advance in technology; well-established production systems in equipment, providing high-quality biologic drugs and increased productivity, is possible. This, in turn, increases the demand of upstream bioprocessing equipment market in biopharmaceutical industry. Besides this, upsurge in the requirement for cell therapy research, antibody production, drug discovery, monoclonal antibody and recombinant protein productions are also the major drivers for the upstream bioprocessing equipment market.

Furthermore, the presence of all systems used in bioprocessing units such as bioreactors, membrane absorbers, bioprocess containers, disposable mixers, and samplers in single-use bioprocessing units are estimated to propel the market growth. However, the requirement for skilled labor and cost constraints encountered in setting up an upstream processing unit and its maintenance along with the challenges to eliminate contamination and the space required for the setup are behaving as major restraining factors for the growth of upstream bioprocessing equipment market.

Key Players

  • GE Healthcare
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Boehringer Ingelheim Pharma GmbH & Co.KG,
  • BiOZEEN
  • Merck KGaA
  • Thermo Fisher Scientific
  • Katalyst Bio Engineering
  • ABEC Biopharmaceutical Manufacturing
  • Bionet Engineering
  • Lonza- Pharma & Biotech
  • Corning

Scope & Context

Overview of the Parent Market

Analyst View

Segmentation

The Global Upstream Bioprocessing Equipment Market is segmented as follows:

  • By Cell line Type Market Size & Y-O-Y Growth Analysis
  • By Processing Type Market Size & Y-O-Y Growth Analysis 
  • By End-User Market Size & Y-O-Y Growth Analysis
  • By Region Market Size & Y-O-Y Growth Analysis

Market Dynamics

Supply & Demand Risk

Competitive Landscape

Porter’s Five Force Model

Geographical Economic Activity

Key Players (respective SWOT Analysis) and their Strategies and Product Portfolio

Recent Trends and Developments

Industry Growth Drivers and Challenges

Key Information for Players to establish themselves in current dynamic environment

kry Answers

SELECT LICENSE TYPE

KEY BENEFITS

  • DIRECT ANALYST ASSISTANCE

    Direct access to analyst to help you understand the market in a better way to handle your critical question

  • CUSTOMIZE AS PER YOUR NEED

    Citing your business specific requirement our consultant would assist you ensuring targeted goal is achieved

  • DISCOUNT ON CUSTOMISATION

    Get 10% free customization

  • QUALITY ASSURED

    Great focus on accuracy and quality of the research

Connect With Us

Call us

(U.S.) - +1 646 586 9123
(Canada) - +1 437 889 3230
(U.K.) - +44 203 608 5919
(India) - + 91 120 660 5495
Email: info@researchnester.com

Ask The Analyst

Delivery Center

Ansal Corporate Park, Plot no 7A/1,
Tower A1,
Sector 142 Noida., 201301 India
info@researchnester.com

US Office

77 Water Street 8th Floor,
New York, New York, 10005
Phone : +1 646 586 9123
info@researchnester.com

Canada (Toronto)

Phone : +1 437 889 3230
info@researchnester.com

UK Office (London)

Phone : +44 203 608 5919
info@researchnester.com

Copyright © 2018 Research Nester. All rights reserved

Top